265.1 Elucidating the role of CD8+ cells in IL-2complex-mediated immunomodulation
Ms. Romy Steiner, Austria
265.2 Assessing the Potency of Autologous MSCs by correlating Serum IDO levels and regulatory T cell in Living-Donor Kidney Transplant Recipients
Prof. Omaima M Sabek, United States
265.3 Advancing CD8+ Treg cell therapy to the clinic for the treatment of kidney transplanted patients
Carole Guillonneau, France
265.4 The first report of three-way macrochimerism and alloreactivity using single cell profiling in a patient receiving multivisceral transplantation following loss of an initial liver-intestine transplant
Dr. Megan Sykes, United States
265.5 T regulatory cell phenotypes in renal transplant patients with long surviving graft, increased Th2-like Treg and reduced Th1- and Th17-like Treg
Prof. Bruce M Hall, Australia
265.6 Rictor-mediated macrophage activation ameliorates antibody-mediated rejection of renal allografts by targeting p65 ubiquitination and NLRP3 transcription
Dr. Ming Zheng, People's Republic of China
265.7 Human CD4+CD25+CD127lo Treg can be activated in vitro with alloantigen and rIL-4 to induce receptor for interleukin 5 (IL-5Ra)
Dr. Nirupama D Verma PhD, Australia
265.8 Characterising pancreatic organoids from hereditary pancreatitis patients and their viability as a disease model
Mr. James Daniel Zuiani, Australia
265.9 CD80/CD86-CD28 signal blockade augments the donor-alloantigen-specific inhibitory function of natural regulatory T cells
Mrs. Kyoko Yogo, Japan
265.10 N-acetylcysteine and liver transplant. Advantages of its administration in multi-organ donors especially during a world economical crisis. Long-term sub-group analysis in a randomized study
Prof. Francesco D'Amico, Italy
265.11 ISL1-overexpressing BMSCs attenuate renal ischemia-reperfusion injury by suppressing apoptosis and oxidative stress through the paracrine action
Dr. Jiale Wang, People's Republic of China
265.12 NLRP3 inhibition prevented graft infiltration of inflammatory macrophages leading to long-term graft acceptance in mouse heart transplantation
Dr. Takuya Harada, Japan
265.13 Features of monitoring kidney transplant recipients during pregnancy and the postpartum period